Patents by Inventor Walter Gall

Walter Gall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of assessing pancreatic beta-cell function
    Patent number: 10302663
    Abstract: Biomarkers relating to pancreatic Beta-cell function, pancreatic Beta-cell glucose sensitivity, insulin resistance, and/or pancreatic Beta-cell-related disorders are provided. Methods based on the same biomarkers are also provided.
    Type: Grant
    Filed: September 11, 2012
    Date of Patent: May 28, 2019
    Assignee: METABOLON, INC.
    Inventors: Walter Gall, Kay A. Lawton
  • Biomarkers for cardiovascular diseases and methods using the same
    Patent number: 10175233
    Abstract: Biomarkers relating to cardiovascular disease, including atherosclerosis and cardiomyopathy, are provided, as well as methods for using such biomarkers as biomarkers for cardiovascular disease. In addition, methods for modulating the respective disorders or conditions of a subject are also provided. Also provided are suites of small molecule entities as biomarkers for cardiovascular disease, including atherosclerosis and cardiomyopathy.
    Type: Grant
    Filed: December 21, 2015
    Date of Patent: January 8, 2019
    Assignee: METABOLON, INC.
    Inventors: Yun Fu Hu, Costel Chirila, Danny Alexander, Michael Milburn, Matthew W. Mitchell, Walter Gall, Kay A. Lawton
  • Biomarkers Related to Insulin Resistance Progression and Methods Using the Same
    Publication number: 20180203021
    Abstract: Biomarkers relating to insulin resistance and insulin resistance-related disorders are provided, as well as methods for using such biomarkers as biomarkers for insulin resistance, dysglycemia, type-2 diabetes, and cardiovascular disease. In addition, methods for monitoring the respective disorders or conditions of a subject are also provided. Also provided are suites of small molecule entities as biomarkers for insulin resistance, dysglycemia, type-2 diabetes, and cardiovascular disease.
    Type: Application
    Filed: January 16, 2018
    Publication date: July 19, 2018
    Inventors: Walter GALL, Jeffery Edmond Cobb, Kirk Lane Pappan
  • Biomarkers related to insulin resistance progression and methods using the same
    Patent number: 9910047
    Abstract: Biomarkers relating to insulin resistance and insulin resistance-related disorders are provided, as well as methods for using such biomarkers as biomarkers for insulin resistance, dysglycemia, type-2 diabetes, and cardiovascular disease. In addition, methods for monitoring the respective disorders or conditions of a subject are also provided. Also provided are suites of small molecule entities as biomarkers for insulin resistance, dysglycemia, type-2 diabetes, and cardiovascular disease.
    Type: Grant
    Filed: January 16, 2014
    Date of Patent: March 6, 2018
    Assignee: Metabolon, Inc.
    Inventors: Walter Gall, Jeffery Edmond Cobb, Kirk Lane Pappan
  • Biomarkers for Pre-Diabetes, Cardiovascular Diseases, and other Metabolic-Syndrome Related Disorders and Methods Using the Same
    Publication number: 20160178620
    Abstract: Biomarkers relating to insulin resistance, pre-diabetes, type-2 diabetes, metabolic syndrome, atherosclerosis, and cardiomyopathy are provided, as well as methods for using such biomarkers as biomarkers for insulin resistance, pre-diabetes, type-2 diabetes, metabolic syndrome, atherosclerosis, and cardiomyopathy. In addition, methods for modulating the respective disorders or conditions of a subject are also provided. Also provided are suites of small molecule entities as biomarkers for insulin resistance, pre-diabetes, type-2 diabetes, metabolic syndrome, atherosclerosis, and cardiomyopathy.
    Type: Application
    Filed: December 21, 2015
    Publication date: June 23, 2016
    Inventors: Yun Fu HU, Costel CHIRILA, Danny ALEXANDER, Michael MILBURN, Matthew W. MITCHELL, Walter GALL, Kay A. LAWTON
  • Biomarkers for insulin resistance and methods using the same
    Patent number: 9250225
    Abstract: Biomarkers relating to insulin resistance are provided, as well as methods for using the same as biomarkers for insulin resistance. Also provided are suites of small molecule entities as biomarkers for insulin resistance.
    Type: Grant
    Filed: July 7, 2014
    Date of Patent: February 2, 2016
    Assignee: Metabolon, Inc.
    Inventors: Yun Fu Hu, Costel Chirila, Danny Alexander, Michael Milburn, Matthew W. Mitchell, Walter Gall, Kay A. Lawton
  • Biomarkers Related to Insulin Resistance Progression and Methods Using the Same
    Publication number: 20150362510
    Abstract: Biomarkers relating to insulin resistance and insulin resistance-related disorders are provided, as well as methods for using such biomarkers as biomarkers for insulin resistance, dysglycemia, type-2 diabetes, and cardiovascular disease. In addition, methods for monitoring the respective disorders or conditions of a subject are also provided. Also provided are suites of small molecule entities as biomarkers for insulin resistance, dysglycemia, type-2 diabetes, and cardiovascular disease.
    Type: Application
    Filed: January 16, 2014
    Publication date: December 17, 2015
    Inventors: Walter GALL, Jeffrey Edmond COBB, Kirk Lane PAPPAN
  • Biomarkers Related to Insulin Resistance and Methods Using the Same
    Publication number: 20150065460
    Abstract: Biomarkers relating to pancreatic Beta-cell function, pancreatic Beta-cell glucose sensitivity, insulin resistance, and/or pancreatic Beta-cell-related disorders are provided. Methods based on the same biomarkers are also provided.
    Type: Application
    Filed: September 11, 2012
    Publication date: March 5, 2015
    Inventors: Walter Gall, Kay A. Lawton
  • Biomarkers for Pre-Diabetes, Cardiovascular Diseases, and Other Metabolic-Syndrome Related Disorders and Methods Using the Same
    Publication number: 20150005195
    Abstract: Biomarkers relating to insulin resistance, pre-diabetes, type-2 diabetes, metabolic syndrome, atherosclerosis, and cardiomyopathy are provided, as well as methods for using such biomarkers as biomarkers for insulin resistance, pre-diabetes, type-2 diabetes, metabolic syndrome, atherosclerosis, and cardiomyopathy. In addition, methods for modulating the respective disorders or conditions of a subject are also provided. Also provided are suites of small molecule entities as biomarkers for insulin resistance, pre-diabetes, type-2 diabetes, metabolic syndrome, atherosclerosis, and cardiomyopathy.
    Type: Application
    Filed: July 7, 2014
    Publication date: January 1, 2015
    Inventors: Yun Fu HU, Costel Chirila, Danny Alexander, Michael Milburn, Matthew W. Mitchell, Walter Gall, Kay A. Lawton
  • Biomarkers for impaired glucose tolerance and methods using the same
    Patent number: 8809008
    Abstract: Biomarkers relating to insulin resistance, pre-diabetes, type-2 diabetes, metabolic syndrome, atherosclerosis, and cardiomyopathy are provided, as well as methods for using such biomarkers as biomarkers for insulin resistance, pre-diabetes, type-2 diabetes, metabolic syndrome, atherosclerosis, and cardiomyopathy. In addition, methods for modulating the respective disorders or conditions of a subject are also provided. Also provided are suites of small molecule entities as biomarkers for insulin resistance, pre-diabetes, type-2 diabetes, metabolic syndrome, atherosclerosis, and cardiomyopathy.
    Type: Grant
    Filed: August 14, 2013
    Date of Patent: August 19, 2014
    Assignee: Metabolon, Inc.
    Inventors: Yun Fu Hu, Costel Chirila, Danny Alexander, Michael Milburn, Matthew W. Mitchell, Walter Gall, Kay A. Lawton
  • Biomarkers for Pre-Diabetes, Cardiovascular Diseases, and Other Metabolic-Syndrome Related Disorders and Methods Using the Same
    Publication number: 20130338031
    Abstract: Biomarkers relating to insulin resistance, pre-diabetes, type-2 diabetes, metabolic syndrome, atherosclerosis, and cardiomyopathy are provided, as well as methods for using such biomarkers as biomarkers for insulin resistance, pre-diabetes, type-2 diabetes, metabolic syndrome, atherosclerosis, and cardiomyopathy. In addition, methods for modulating the respective disorders or conditions of a subject are also provided. Also provided are suites of small molecule entities as biomarkers for insulin resistance, pre-diabetes, type-2 diabetes, metabolic syndrome, atherosclerosis, and cardiomyopathy.
    Type: Application
    Filed: August 14, 2013
    Publication date: December 19, 2013
    Inventors: Yun Fu Hu, Costel Chirila, Danny Alexander, Michael Milburn, Matthew W. Mitchell, Walter Gall, Kay A. Lawton
  • Biomarkers for monitoring insulin resistance and methods using the same
    Patent number: 8546098
    Abstract: Biomarkers relating to insulin resistance are provided, as well as methods for using such biomarkers as biomarkers for insulin resistance. These biomarkers may be used to monitor the progression or regression of insulin resistance or to monitor the efficacy of insulin resistance treatment. Also provided are suites of small molecule entities as biomarkers for insulin resistance.
    Type: Grant
    Filed: April 27, 2012
    Date of Patent: October 1, 2013
    Assignee: Metabolon, Inc.
    Inventors: Yun Fu Hu, Costel Chirila, Danny Alexander, Michael Milburn, Matthew W. Mitchell, Walter Gall, Kay A. Lawton
  • Biomarkers for Pre-Diabetes, Cardiovascular Diseases, and Other Metabolic-Syndrome Related Disorders and Methods Using the Same
    Publication number: 20120208215
    Abstract: Biomarkers relating to insulin resistance, pre-diabetes, type-2 diabetes, metabolic syndrome, atherosclerosis, and cardiomyopathy are provided, as well as methods for using such biomarkers as biomarkers for insulin resistance, pre-diabetes, type-2 diabetes, metabolic syndrome, atherosclerosis, and cardiomyopathy. In addition, methods for modulating the respective disorders or conditions of a subject are also provided. Also provided are suites of small molecule entities as biomarkers for insulin resistance, pre-diabetes, type-2 diabetes, metabolic syndrome, atherosclerosis, and cardiomyopathy.
    Type: Application
    Filed: April 27, 2012
    Publication date: August 16, 2012
    Applicant: METABOLON, INC.
    Inventors: Yun Fu HU, Costel CHIRILA, Danny ALEXANDER, Michael MILBURN, Matthew W. MITCHELL, Walter GALL, Kay A. LAWTON
  • Method for determining insulin sensitivity with biomarkers
    Patent number: 8187830
    Abstract: Biomarkers relating to insulin resistance, pre-diabetes, type-2 diabetes, metabolic syndrome, atherosclerosis, and cardiomyopathy are provided, as well as methods for using such biomarkers as biomarkers for insulin resistance, pre-diabetes, type-2 diabetes, metabolic syndrome, atherosclerosis, and cardiomyopathy. In addition, methods for modulating the respective disorders or conditions of a subject are also provided. Also provided are suites of small molecule entities as biomarkers for insulin resistance, pre-diabetes, type-2 diabetes, metabolic syndrome, atherosclerosis, and cardiomyopathy.
    Type: Grant
    Filed: July 17, 2008
    Date of Patent: May 29, 2012
    Assignee: Metabolon, Inc.
    Inventors: Yun Fu Hu, Costel Chirila, Danny Alexander, Michael Milburn, Matthew W. Mitchell, Walter Gall, Kay A. Lawton
  • Biomarkers Related to Insulin Resistance and Methods using the Same
    Publication number: 20120122981
    Abstract: Biomarkers relating to glucose disposal rate, insulin resistance, and/or insulin resistance-related disorders are provided. Methods based on the same biomarkers are also provided.
    Type: Application
    Filed: March 31, 2010
    Publication date: May 17, 2012
    Inventors: Yun Fu Hu, Costel Chirila, Danny Alexander, Michael Milburn, Matthew W. Mitchell, Walter Gall, Kay A. Lawton
  • Biomarkers for pre-diabetes, cardiovascular diseases, and other metabolic-syndrome related disorders and methods using the same
    Publication number: 20090155826
    Abstract: Biomarkers relating to insulin resistance, pre-diabetes, type-2 diabetes, metabolic syndrome, atherosclerosis, and cardiomyopathy are provided, as well as methods for using such biomarkers as biomarkers for insulin resistance, pre-diabetes, type-2 diabetes, metabolic syndrome, atherosclerosis, and cardiomyopathy. In addition, methods for modulating the respective disorders or conditions of a subject are also provided. Also provided are suites of small molecule entities as biomarkers for insulin resistance, pre-diabetes, type-2 diabetes, metabolic syndrome, atherosclerosis, and cardiomyopathy.
    Type: Application
    Filed: July 17, 2008
    Publication date: June 18, 2009
    Applicant: Metabolon, Inc.
    Inventors: Yun Fu Hu, Costel Chirila, Danny Alexander, Michael Milburn, Matthew W. Mitchell, Walter Gall, Kay A. Lawton